Concepedia

Elizabeth Kell

EK

Statistics

Publications

4

Citations

491

H-Index

4

Active since

2008

Affiliations

Fred Hutch Cancer Center(Current)

Elizabeth Kell is an author at Fred Hutch Cancer Center specializing in recist criteria, thyroid cancer, and medicine.

Publications per year

2008–2014

4

Publications

4

Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation

Laurie L. Carr, David A. Mankoff, Bernardo Goulart et al. · Clinical Cancer Research · 2010 · 418 citations · Full text

, , +17

Phase II study of sunitinib in iodine refractory, well-differentiated thyroid cancer (WDTC) and metastatic medullary thyroid carcinoma (MTC)

Bernardo Goulart, Laurie Carr, R. G. Martins et al. · Journal of Clinical Oncology · 2008 · 32 citations

, , +17

Phase II trial of continuous dosing of sunitinib in advanced, FDG-PET avid, medullary thyroid carcinoma (MTC) and well-differentiated thyroid cancer (WDTC)

Laurie Carr, Bernardo Goulart, Renato Martins et al. · Journal of Clinical Oncology · 2009 · 21 citations

, , +16

Teaching Students with Disabilities in Post-secondary Landscapes: Navigating Elements of Inclusion, Differentiation, Universal Design for Learning, and Technology

Wendy L. Kraglund‐Gauthier, David C. Young, Elizabeth Kell · 2014 · 20 citations

, , +17

1–4 of 4